코리네박테리움 속 박테리아 및 이로부터 유래된 미니셀 그리고 이의 용도
    43.
    发明公开
    코리네박테리움 속 박테리아 및 이로부터 유래된 미니셀 그리고 이의 용도 有权
    红霉素 细菌和小细胞从其衍生的细菌和其使用

    公开(公告)号:KR1020160107465A

    公开(公告)日:2016-09-19

    申请号:KR1020150030224

    申请日:2015-03-04

    Abstract: 본발명은코리네박테리움속 박테리아및 코리네박테리움속 박테리아유래미니셀을포함하는것을특징으로하는약물전달체조성물에관한것으로, 다른박테리아(예컨대, 대장균(), 살모넬라속박테리아. 바실러스속 박테리아등) 또는다른박테리아유래약물전달체에비해상대적으로인체에사용하기에더 안전한장점을갖는다. 본발명은항암용약물단백질발현컨트스럭트(단백질발현재조합벡터등)를포함하는경우항암용약물단백질의과발현, 생체내에서의효과적인단백질발현조절, 표적인자의발현을통한표적화기술을제공한다. 또한, 본발명은생체내에서안정적으로약물을전달할수 있으므로, 항암치료효과를극대화할수 있다.

    Abstract translation: 本发明涉及棒状杆菌属细菌,以及一种药物载体组合物,其包含衍生自棒状杆菌内的细菌的小细胞,与来自其它细菌的其它药物载体相比,其有益于在人体中更安全地使用 例如,大肠杆菌,沙门氏菌和芽孢杆菌内的细菌)。 当与抗癌药物 - 蛋​​白质表达构建体(例如重组蛋白表达载体)组合时,本发明通过抗癌药物蛋白质的过表达,蛋白质表达的有效体内调节和靶因子的表达来提供靶向技术。 此外,本发明可以通过进行稳定的体内药物递送来优化抗癌治疗效果。

    박테리아를 이용한 고형암 치료제
    45.
    发明公开
    박테리아를 이용한 고형암 치료제 有权
    使用细菌的固体癌剂

    公开(公告)号:KR1020160039495A

    公开(公告)日:2016-04-11

    申请号:KR1020140132645

    申请日:2014-10-01

    CPC classification number: C12N1/20 A61K35/74 C12N1/00

    Abstract: 본발명은프로모터에작동가능하게연결된 L-아스파라기나아제(L-ASNase)를암호화하는폴리뉴클레오티드를포함하는유전자컨스트럭트로형질전환되어상기 L-아스파라기나아제가종양사이트에서선택적으로발현되는약독화살모넬라균주를제공한다.

    Abstract translation: 本发明涉及使用细菌的固体癌治疗剂。 根据本发明,提供了一种减毒沙门氏菌菌株,其通过转化到包含多核苷酸的基因构建体来选择性地表达L-天冬酰胺酶(L-ASNase),所述多核苷酸编码L-天冬酰胺酶(L-ASNase),其可操作地偶联到 启动子。

    개선된 유전자 발현 유도능을 갖는 살모넬라 및 그의 용도
    47.
    发明公开
    개선된 유전자 발현 유도능을 갖는 살모넬라 및 그의 용도 有权
    具有改进的可诱导基因表达及其用途的沙门氏菌

    公开(公告)号:KR1020130102668A

    公开(公告)日:2013-09-23

    申请号:KR1020120023637

    申请日:2012-03-07

    CPC classification number: C12N1/20 A61K48/00 C12N15/74 C12R1/42

    Abstract: PURPOSE: Salmonella which improves gene expression is provided to maximize treatment effect by highly expressing a foreign gene from a Salmonella strain for therapy even if a small amount of L-arabinose is administered. CONSTITUTION: An attenuated Salmonella sp. strain has inactivated intrinsic ppGpp producing genes and ara operon. The ppGpp producing gene is relA and spoT. A recombinant attenuated Salmonella sp. strain is prepared by transducing a gene construct containing a polynucleotide encoding a foreign gene which is operatively linked to ara promoter or a nucleic acid molecule for suppressing gene expression. A drug delivery system for targeting cancer or infarction contains the attenuated Salmonella sp. strain or the recombinant attenuated Salmonella sp. strain and a drug delivered to a cancer or infarction tissue by the strains. [Reference numerals] (AA) Concentration of L-arabinose (%)

    Abstract translation: 目的:提供改善基因表达的沙门氏菌,以便即使施用少量的L-阿拉伯糖,也可以通过高度表达来自沙门氏菌属菌株的外源基因来治疗,以最大化治疗效果。 构成:减毒沙门氏菌 菌株已经灭活了内生的ppGpp产生基因和ara操纵子。 ppGpp产生基因是relA和spoT。 重组减毒沙门氏菌 通过转导含有编码与ara启动子有用的外源基因的多核苷酸的基因构建体或用于抑制基因表达的核酸分子来制备菌株。 用于靶向癌症或梗死的药物递送系统包含减毒的沙门氏菌属。 菌株或重组减毒沙门氏菌 菌株和通过菌株递送至癌症或梗塞组织的药物。 (AA)L-阿拉伯糖浓度(%)

    선택적 경색 조직 타겟팅 박테리아 및 그의 용도
    49.
    发明公开
    선택적 경색 조직 타겟팅 박테리아 및 그의 용도 有权
    选择性感染的组织 - 靶向细菌及其用途

    公开(公告)号:KR1020120030391A

    公开(公告)日:2012-03-28

    申请号:KR1020117028233

    申请日:2010-05-27

    Abstract: PURPOSE: A selective infart-tissue-targeting bacteria and use thereof are provided to improve affinity and specificity to infarction myocardium or infarction brain, thereby reducing transfection other than heart. CONSTITUTION: A drug delivery system for infarcted tissues includes obligatory anaerobic or facultative anaerobic bacteria. The bactia are Salmonella, Clostridium, Bifidobacterium, E. coli, Yersinia enterocohtica, Listeria monocytogenies, Mycoplasma hominis, or Streptococcus. The bacteria are mutants which are deficient in ppGpp synthesis function. The bacteria comprise ppGpp for ppGpp synthesis, inactivated relA gene which codes synthetase or spoT gene. The infarction indicates either myocardial infarction or cerebral infarction. A pharmaceutical composition for treating the infarction comprises effective dose of drug delivery system and a pharmaceutically allowed carrier. The drug carrier includes the infarction treatment drug.

    Abstract translation: 目的:提供选择性的infart组织靶向细菌及其用途,以改善对梗塞心肌或梗死脑的亲和力和特异性,从而减少心脏以外的转染。 构成:用于梗塞组织的药物递送系统包括必需的厌氧或兼性厌氧细菌。 细菌是沙门氏菌属,梭菌属,双歧杆菌属,大肠杆菌,肠易耶一肠炎,单核细胞增多性李斯特菌,人支原体或链球菌。 细菌是缺乏ppGpp合成功能的突变体。 细菌包含ppGpp用于ppGpp合成,灭活的relA基因编码合成酶或spoT基因。 梗死表示心肌梗塞或脑梗塞。 用于治疗梗死的药物组合物包括有效剂量的药物递送系统和药学上允许的载体。 药物载体包括梗死治疗药物。

    소동물 형광영상 동시관찰 광학분자영상장치
    50.
    发明公开
    소동물 형광영상 동시관찰 광학분자영상장치 有权
    用于实时荧光成像的双视觉光学分子成像装置

    公开(公告)号:KR1020110018217A

    公开(公告)日:2011-02-23

    申请号:KR1020090075902

    申请日:2009-08-17

    Abstract: PURPOSE: An optical molecular imaging device for simultaneously monitoring the fluorescence imaging of small animal is provided to reduce the manipulation steps of a user by simultaneously taking the two images of one object. CONSTITUTION: An optical molecular imaging device for simultaneously monitoring the fluorescence imaging of small animal comprises a housing(110), a movable stage(120), an irradiating unit(130), and a photographic unit(140). The housing forms the space shut tightly. The movable stage comprises a table(121), in which the subject locates, and is installed in the lower part of the housing. The irradiating unit radiates the light for taking a photograph of the subject.

    Abstract translation: 目的:提供用于同时监测小动物荧光成像的光学分子成像装置,以通过同时拍摄一个对象的两个图像来减少用户的操纵步骤。 构成:用于同时监测小动物的荧光成像的光学分子成像装置包括壳体(110),可移动台(120),照射单元(130)和照相单元(140)。 外壳形成紧密的空间。 可移动台包括被检体位于其中并安装在壳体下部的工作台(121)。 照射单元照射用于拍摄被摄体的照片的光。

Patent Agency Ranking